Uncategorized – Clinical Trial Results

Dr. Thomas Crawford and Dr. C. Michael Gibson Discuss: Preliminary Results of Randomized Trial of New vs. Reconditioned Pacemakers for Patients Unable to Obtain a New Device in Low- and Middle-Income Countries: The My Heart Your Heart (MHYH) Randomized Trial

November 17, 2024

Disclosures: TBD

Dr. Ankeet Bhatt and Dr. C. Michael Gibson Discuss: Electronic Nudges to Increase Influenza Vaccination Among Patients With History of Myocardial Infarction: Insights From 3 Randomized Clinical Trials Enrolling >2 Million Patients (NUDGE-FLU)

November 17, 2024

Disclosures: TBD

Dr. Dorairaj Prabhakaran and Dr. C. Michael Gibson Discuss: TOPSPIN- A Three-Arm Randomized Trial for Treatment Optimization of Blood Pressure With Single-Pill Combinations In India

November 17, 2024

Disclosures: TBD

Stephan Baldus and Dr. C Michael Gibson Discuss: MATTERHORN: Atrial MR SubgroupTranscatheter Repair Versus Surgery in Atrial Mitral Regurgitation: Results From the MATTERHORN Trial

October 30, 2024

Disclosures: TBD

Olivier F Bertrand and Dr. C Michael Gibson Discuss: TARGET IVInternational Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System

October 30, 2024

Disclosures: TBD

Expert Roundtable – Vulnerable Plaque, Past, Present and Future

October 30, 2024

Disclosure: Sponsored by Cleerly Health

Sanjit S. Jolly and Dr. C Michael Gibson Discuss: CLEAR SYNERGY (OASIS 9)A 2×2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction: The Results of the Colchicine Factorial

October 29, 2024

Disclosures: TBD

Dr. David Schnieder and I discuss a new cardiovascular risk marker: Platelet pFCG

October 24, 2024

Disclosures: TBD

Dr. Jacob Eifer Møller Presents: Percutaneous Transvalvular Micro-axial Flow Pump In Infarct Related Cardiogenic Shock. Results Of The Danger-shock Trial Slides

April 11, 2024

Disclosures: TBD

Dr. Michael Nanna and Dr. Gibson discuss the PRECISE trial.

February 14, 2024

Disclosures: s/b HeartFlow